Evidence map›Paper›PMID 26446987›Full record

ArticleNucleic acids research2015

MiRNA-891a-5p mediates HIV-1 Tat and KSHV Orf-K1 synergistic induction of angiogenesis by activating NF-κB signaling.

Shuihong Yao, Minmin Hu, Tingting Hao, Wan Li, Xue Xue, Min Xue, Xiaofei Zhu, Feng Zhou, Di Qin, Qin Yan and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Viral oncogenesis in cancer: from mechanisms to therapeutics.Signal transduction and targeted therapy · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Shuihong YaoState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, P.R. China Key Laboratory of Pathogen Biology of Jiangsu Province, Nanjing Medical University, Nanjing, P.R. China Department of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China Medical School, Quzhou College of Technology, Quzhou 324000, P.R. China.
Minmin HuDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China.
Tingting HaoDepartment of Medical Laboratory, The Affiliated Hospital of Xuzhou Medical College, Xuzhou 221000, P.R. China.
Wan LiDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China.
Xue XueDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China.
Min XueDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China.
Xiaofei ZhuDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China.
Feng ZhouDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China.
Di QinDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China.
Qin YanDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China yanqin@njmu.edu.cn.
Jianzhong ZhuCancer Virology Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA.
Shou-Jiang GaoDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Chun LuState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, P.R. China Key Laboratory of Pathogen Biology of Jiangsu Province, Nanjing Medical University, Nanjing, P.R. China Department of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China clu@njmu.edu.cn.
Nanjing Medical University · CNAffiliated Hospital of Xuzhou Medical College · CNUniversity of Southern California · USUPMC Hillman Cancer Center · US

Funding

Roles of the K3 and K5 in KSHV Persistence and PathogenesisP01CA180779 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2013 to 2017
$7.3M
Regulation of KSHV replication by N6-methyladenosine (m6A) - Diversity SupplementR01CA124332 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GAO, SHOU-JIANG · 2007 to 2025
$5.0M
Mechanism of KSHV-induced angiogenesisR01CA132637 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GAO, SHOU-JIANG · 2008 to 2020
$3.6M
HISTONE MODIFIERS IN ORAL KSHV INFECTION AND MALIGNANCIESR01DE025465 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GAO, SHOU-JIANG · 2015 to 2019
$2.0M
Targeting KSHV malignancies and persistent infectionR01CA197153 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GAO, SHOU-JIANG · 2015 to 2019
$1.9M
KSHV microRNAs in cellular transformation and tumorigenesisR01CA177377 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GAO, SHOU-JIANG · 2013 to 2015
$596k
NCI NIH HHS P01 CA180779NCI NIH HHS R01 CA124332NCI NIH HHS R01 CA132637NCI NIH HHS R01CA132637NCI NIH HHS R01 CA177377NCI NIH HHS R01CA177377NCI NIH HHS R01 CA197153NIDCR NIH HHS R01 DE025465
6 · The paper itself

Abstract

Co-infection with HIV-1 and Kaposi's sarcoma-associated herpesvirus (KSHV) is the cause of aggressive AIDS-related Kaposi's sarcoma (AIDS-KS) characterized by abnormal angiogenesis. The impact of HIV-1 and KSHV interaction on the pathogenesis and extensive angiogenesis of AIDS-KS remains unclear. Here, we explored the synergistic effect of HIV-1 Tat and KSHV oncogene Orf-K1 on angiogenesis. Our results showed that soluble Tat or ectopic expression of Tat enhanced K1-induced cell proliferation, microtubule formation and angiogenesis in chorioallantoic membrane and nude mice models. Mechanistic studies revealed that Tat promoted K1-induced angiogenesis by enhancing NF-κB signaling. Mechanistically, we showed that Tat synergized with K1 to induce the expression of miR-891a-5p, which directly targeted IκBα 3' untranslated region, leading to NF-κB activation. Consequently, inhibition of miR-891a-5p increased IκBα level, prevented nuclear translocation of NF-κB p65 and ultimately suppressed the synergistic effect of Tat- and K1-induced angiogenesis. Our results illustrate that, by targeting IκBα to activate the NF-κB pathway, miR-891a-5p mediates Tat and K1 synergistic induction of angiogenesis. Therefore, the miR-891a-5p/NF-κB pathway is important in the pathogenesis of AIDS-KS, which could be an attractive therapeutic target for AIDS-KS.

Indexed as

HIV-1Neovascularization, PhysiologicAnimalsCarcinogenesisCell LineCell ProliferationChick EmbryoHumansI-kappa B ProteinsMaleMembrane ProteinsMice, Inbred BALB CMice, NudeMicroRNAsMicrotubulesNF-kappa BI-kappa B ProteinsK1 protein, Human herpesvirus 8Membrane ProteinsMicroRNAsNF-kappa BNF-KappaB Inhibitor alphaNFKBIA protein, humanNfkbia protein, mousetat Gene Products, Human Immunodeficiency VirusViral Envelope ProteinsViral Proteins

Identifiers

PMID26446987
PMCPMC4627096
OpenAlexW1925684171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.